Oncosil Medical Ltd has released a press release.
First year anniversary of the OSPREY post-marketing registry
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Oral presentation at The Mayo Clinic IMPACT Course
- Further commercial milestones achieved in Spain
- Additional Binding Commitment Received for Entitlement Offer
- Non-renounceable Rights Issue Offer Prospectus
- Commitment received for Offer and updated Timetable
Later from OncoSil Medical
- OncoSil to streamline operating structure
- First patient enrolled in the TRIPP-FFX Clinical Study
- First patient treatment in Italy
- Ethics Committee Approves PANCOSIL Clinical Trial
- Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical